145 related articles for article (PubMed ID: 15869062)
1. Experience of hepatitis C among current or former heroin users attending general practice.
Cullen W; Kelly Y; Stanley J; Langton D; Bury G
Ir Med J; 2005 Mar; 98(3):73-4. PubMed ID: 15869062
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
3. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.
Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B
Drug Alcohol Depend; 2008 Jan; 93(1-2):141-7. PubMed ID: 17997050
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
Day C; Ross J; Dolan K
Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
[TBL] [Abstract][Full Text] [Related]
5. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
[TBL] [Abstract][Full Text] [Related]
6. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M
Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277
[TBL] [Abstract][Full Text] [Related]
7. Drug users attending general practice in Eastern Regional Health Authority (ERHA) area.
Cullen W; Bury G; Barry J; O'Kelly F
Ir Med J; 2000 Oct; 93(7):214-7. PubMed ID: 11142958
[TBL] [Abstract][Full Text] [Related]
8. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
[TBL] [Abstract][Full Text] [Related]
9. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
11. Methadone maintenance treatment can be provided in a primary care setting without increasing methadone-related mortality: the Sheffield experience 1997-2000.
Keen J; Oliver P; Mathers N
Br J Gen Pract; 2002 May; 52(478):387-9. PubMed ID: 12014536
[TBL] [Abstract][Full Text] [Related]
12. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
13. Zopiclone misuse: an update from Dublin.
Bannan N; Rooney S; O'connor J
Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
[TBL] [Abstract][Full Text] [Related]
14. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
[TBL] [Abstract][Full Text] [Related]
15. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y
Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439
[TBL] [Abstract][Full Text] [Related]
16. Experience of heroin overdose among drug users attending general practice.
Cullen W; Bury G; Langton D
Br J Gen Pract; 2000 Jul; 50(456):546-9. PubMed ID: 10954935
[TBL] [Abstract][Full Text] [Related]
17. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment.
van der Zanden BP; Dijkgraaf MG; Blanken P; van Ree JM; van den Brink W
Drug Alcohol Depend; 2007 Jan; 86(1):84-90. PubMed ID: 16806740
[TBL] [Abstract][Full Text] [Related]
18. Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China.
Du WJ; Xiang YT; Wang ZM; Chi Y; Zheng Y; Luo XN; Cai ZJ; Ungvari GS; Gerevich J
Drug Alcohol Depend; 2008 Apr; 94(1-3):158-64. PubMed ID: 18164146
[TBL] [Abstract][Full Text] [Related]
19. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
20. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
Canfield KM; Smyth E; Batki SL
Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
